SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Generic Pharmasec soars on executing order from Reliance Group

27 Jul 2021 Evaluate

Generic Pharmasec is currently trading at Rs. 9.32, up by 0.11 points or 1.19% from its previous closing of Rs. 9.21 on the BSE.

The scrip opened at Rs. 9.06 and has touched a high and low of Rs. 9.37 and Rs. 9.06 respectively. So far 161141 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 14.02 on 14-Oct-2020 and a 52 week low of Rs. 7.11 on 03-May-2021.

Last one week high and low of the scrip stood at Rs. 9.49 and Rs. 9.04 respectively. The current market cap of the company is Rs. 253.33 crore.

The promoters holding in the company stood at 59.96% and Non-Institutions held 40.04%.

Generic Pharmasec has successfully executed an order from Reliance Group for upgrading Point of Care Diagnostics by installing Abbot Point of Care I-Stat Blood Analysers at their group hospitals namely, Sir H. N. Reliance Hospital at Mumbai, Reliance Foundation Hospital at Jamnagar, Reliance Industries Hospitals at Bharuch and at Surat.

The company is in dialogue with Reliance Group for further orders and implementation for their Group hospitals at various other locations.

Generic Pharmasec will now increase its focus on creating high value propositions for all hospitals in India for all their Critical Diagnostic Requirements. To Increase the footprint in the country & improve access to Critical Diagnostic Solutions in Tier-2 & Tier-3 towns, Generic Pharmasec will appoint 15 new sub-distributors over the course of the next 24 months in such identified towns across the country.

Genpharmasec Share Price

1.13 0.00 (0.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×